GlassScriptPhysician profile
Vanna S Gold
NPI 1669818910
$1,527.38
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $609 · 2021: $460.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $247.39 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $166.88 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $161.94 | 2019-2021 | |
| Glaxosmithkline, LLC. | $138.95 | 2019-2021 | |
| Allergan, INC. | $75.73 | 2019-2020 | |
| Amgen INC. | $71.90 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.90 | 2020-2021 | |
| Amarin Pharma, INC. | $63.07 | 2019-2021 | |
| Abbvie INC. | $52.65 | 2021 | |
| Merck Sharp & Dohme LLC | $51.73 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.76 | 2019-2020 | |
| Pfizer INC. | $49.62 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $44.93 | 2021 | |
| Lilly USA, LLC | $36.39 | 2019-2021 | |
| Eisai INC. | $30.53 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.12 | 2020-2021 | |
| Cranial Technologies, INC | $27.99 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.54 | 2019-2020 | |
| Sanofi Pasteur INC. | $21.81 | 2020 | |
| Ironshore Pharmaceuticals INC. | $15.11 | 2019 | |
| Mission Pharmacal Company | $15.06 | 2019 | |
| Biogen, INC. | $13.87 | 2021 | |
| Astellas Pharma US INC | $13.53 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.53 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.99 | 2019 | |
| Circassia INC. | $12.87 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.59 | 2021 |
9 companies reported research payments only; those appear in the research section below.
Research and ownership
$18,495.54 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanna Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.